 Establishment Labs Holdings Inc. ESTA the Company, a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced the closing of its previously announced public offering of 2,628,571 common shares at 26.25 per share. This includes the exercise in full by the underwriters of their option to purchase up to 342,857 additional common shares. The gross proceeds to Establishment Labs were approximately 69.0 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Establishment Labs. 